FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Janssen Ortho Invokamet Recall

Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle,…

Janssen Ortho L.L.C. · Gurabo, PR

Risk level
Class III
Reported by FDA
Nov 2, 2016
Recall ID
D-0115-2017
Check your lot numberHow we source this data

Summary

Janssen Ortho recalled Invokamet starting Oct 19, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0115-2017 on Nov 2, 2016. Reason: Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Product description

Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60

Lot numbers, UPCs & expiration codes

Lot #: 16GG581X, Exp 09/17

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0115-2017
Classification
Class III
Status
Terminated
Recall initiated
Oct 19, 2016
FDA report date
Nov 2, 2016
Quantity
5346 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Janssen Ortho L.L.C.

Original FDA data

Every field from FDA enforcement report D-0115-2017, exactly as published.

Show all FDA fields
City
Gurabo
State
PR
Status
Terminated
Country
United States
Event ID
75449
Address
Carr # 933 Km 0.1
Code information
Lot #: 16GG581X, Exp 09/17
Postal code
00778
Report date
Nov 2, 2016
Product type
Drugs
Recall number
D-0115-2017
Classification
Class III
Recalling firm
Janssen Ortho L.L.C.
Product quantity
5346 bottles
Termination date
May 14, 2018
Reason for recall
Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Oct 19, 2016
Center classification date
Oct 25, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0115-2017, published Nov 2, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls